» Articles » PMID: 22832194

Assembly and Regulation of the Membrane Attack Complex Based on Structures of C5b6 and SC5b9

Overview
Journal Cell Rep
Publisher Cell Press
Date 2012 Jul 27
PMID 22832194
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the complement system results in formation of membrane attack complexes (MACs), pores that disrupt lipid bilayers and lyse bacteria and other pathogens. Here, we present the crystal structure of the first assembly intermediate, C5b6, together with a cryo-electron microscopy reconstruction of a soluble, regulated form of the pore, sC5b9. Cleavage of C5 to C5b results in marked conformational changes, distinct from those observed in the homologous C3-to-C3b transition. C6 captures this conformation, which is preserved in the larger sC5b9 assembly. Together with antibody labeling, these structures reveal that complement components associate through sideways alignment of the central MAC-perforin (MACPF) domains, resulting in a C5b6-C7-C8β-C8α-C9 arc. Soluble regulatory proteins below the arc indicate a potential dual mechanism in protection from pore formation. These results provide a structural framework for understanding MAC pore formation and regulation, processes important for fighting infections and preventing complement-mediated tissue damage.

Citing Articles

Complement C7 and clusterin form a complex in circulation.

Massri M, Toonen E, Sarg B, Kremser L, Grasse M, Fleischer V Front Immunol. 2024; 15:1330095.

PMID: 38333209 PMC: 10850381. DOI: 10.3389/fimmu.2024.1330095.


Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation.

Tang G, Tang Y, Dhamnaskar K, Hoarty M, Vyasamneni R, Vadysirisack D Front Immunol. 2023; 14:1213920.

PMID: 37622108 PMC: 10446491. DOI: 10.3389/fimmu.2023.1213920.


Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions.

Ruiz-Molina N, Parsons J, Decker E, Reski R Comput Struct Biotechnol J. 2023; 21:1473-1486.

PMID: 36851916 PMC: 9957715. DOI: 10.1016/j.csbj.2023.02.002.


Genome-wide screen in human plasma identifies multifaceted complement evasion of Pseudomonas aeruginosa.

Janet-Maitre M, Pont S, Masson F, Sleiman S, Trouillon J, Robert-Genthon M PLoS Pathog. 2023; 19(1):e1011023.

PMID: 36696456 PMC: 9901815. DOI: 10.1371/journal.ppat.1011023.


C3-dependent effector functions of complement.

Zarantonello A, Revel M, Grunenwald A, Roumenina L Immunol Rev. 2022; 313(1):120-138.

PMID: 36271889 PMC: 10092904. DOI: 10.1111/imr.13147.


References
1.
. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 5):760-3. DOI: 10.1107/S0907444994003112. View

2.
Steckel E, Welbaum B, Sodetz J . Evidence of direct insertion of terminal complement proteins into cell membrane bilayers during cytolysis. Labeling by a photosensitive membrane probe reveals a major role for the eighth and ninth components. J Biol Chem. 1983; 258(7):4318-24. View

3.
Podack E, Tschoop J, MULLER-EBERHARD H . Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly. J Exp Med. 1982; 156(1):268-82. PMC: 2186720. DOI: 10.1084/jem.156.1.268. View

4.
Botto M, Kirschfink M, Macor P, Pickering M, Wurzner R, Tedesco F . Complement in human diseases: Lessons from complement deficiencies. Mol Immunol. 2009; 46(14):2774-83. DOI: 10.1016/j.molimm.2009.04.029. View

5.
Preissner K, Podack E, MULLER-EBERHARD H . The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7. J Immunol. 1985; 135(1):445-51. View